Naproxen
NDC 42192-619, Naproxen, suspension, from Acella Pharmaceuticals, LLC.
- Product NDC
- 42192-619
- Status
- Listed
- Labeler
- Acella Pharmaceuticals, LLC
- Dosage form
- SUSPENSION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA AUTHORIZED GENERIC
- Application
- NDA018965
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42192-619 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN125 mg/5mL
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42192-619-16 | 42192061916 | 473 mL in 1 BOTTLE (42192-619-16) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/7e6f03fb-4b36-4418-9684-f45637abbb78NADAC price for package 42192061916
GET /v1/drugs/nadac/42192061916
Use it
Look up 42192-619 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42192-619 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42192-619. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.